BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Dec 12, 2011
 |  BC Week In Review  |  Clinical News  |  Clinical Results

CV-301: Pilot trial data

Data from a pilot trial in 12 patients with breast cancer showed that monthly CV-301 produced a median TTP and OS of 2.5 and 13.7 months, respectively. One patient had a complete response and 4 patients had stable disease. In 14 patients with ovarian...

Read the full 199 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >